Rebalix
Logo AmundiAmundi · sheet of 10 September 2026
ETF sheet · official issuer and register data

Amundi CAC Transition Climat UCITS ETF

CF1 · FR0010655704 · EUR · domicile France
Equity · France · Sustainable / ESGSFDR art. 8
Index tracked: CAC SBT 1.5 NR Index
TER
0.25%+ trans. 0.09%
Fund size
12 m EUR
Tracking difference
−0.03%3-year avg
🇮🇹 tax rate
white list not published
Replication
Physical
Income
Accumulating
Launch 16 Sept 2008 · costs from the KID as of 2 Sept 2026 · 73 securities held · 7 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 4 Aug 2026
By subscribing to Amundi CAC Transition Climat UCITS ETF, you are investing in a passively managed UCITS whose objective is to replicate as closely as possible the performance of the CAC Transition Climat NR Index (the "Index"), regardless of whether it experiences a positive or negative development. The maximum tracking error objective between the growth of the net asset value of the Fund and that of the Index is indicated in the Fund's prospectus. The Index, net dividends reinvested (dividends, net of tax, paid by the equities in the index are included…

Performance since series start (in euro) — base 100

10 Jul 20178 Sept 2026 · dividends reinvested where declared by the issuer
2018202020222024202619478182
High 194 (21 Oct 2025) · low 78 (18 Mar 2020) · last 182. Past performance is not indicative of future results.

Returns in euro

1 year+3.0%
3 years+15.5%
5 years+27.8%
10 yearsseries too young
Since series start+82.1%

Risk · 1 / 3 / 5 years

Volatility (ann.)15.65%14.72%16.37%
Max drawdown−14.99%−16.02%−21.08%
Sharpe0.070.170.23
Sortino0.110.240.33
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · CF1 · FR00106557041
RebalixCF1 · FR0010655704 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · from issuer-declared series
YearFundIndexTD
2025+12.80%+13.02%−0.23%
2024+1.07%+0.99%+0.08%
2023+17.36%+17.29%+0.06%
2022−7.61%−7.65%+0.05%
2021+28.77%+28.59%+0.18%

Holdings

Portfolio as declared by the issuer · 1 Sept 2026 · 73 securities · top-10 weight = 65.8%
Top holdingsWeight
SCHNEIDER ELECT SE10.5%
AIRBUS SE PARIS9.3%
LVMH MOET HENNESSY LOUIS VUI8.9%
SAFRAN SA8.4%
L OREAL7.3%
SANOFI - PARIS7.2%
ESSILORLUXOTTICA4.1%
HERMES INTERNATIONAL3.9%
DANONE3.3%
LEGRAND SA2.8%
Countries (% of fund)
France100.0%
Sectors (% of fund)
Industrials41.1%Consumer Discretionary17.9%Consumer Staples12.7%Health Care12.1%Information Technology5.4%

Listing venues

ESMA register (FIRDS) and official exchange lists
X13J · Börse Düsseldorf, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange
CF1 · Euronext Paris
+ 8 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.amundietf.it/pdfDocuments/kid-priips/FR0010655704/ENG/DEU
Factsheet · www.amundietf.it/pdfDocuments/monthly-factsheet/FR0010655704/ENG/GBR/I
Prospectus · www.amundietf.it/pdfDocuments/prospectus/FR0010655704/ENG/GBR
The live sheet, always up to date
rebalix.com/en/etf/FR0010655704
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · CF1 · FR00106557042